-+ 0.00%
-+ 0.00%
-+ 0.00%

Leerink Partners Assumes Zentalis Pharmaceuticals at Outperform, Raises Price Target to $8

Benzinga·10/05/2026 13:00:31
Listen to the news
Leerink Partners analyst Asthika Goonewardene assumes Zentalis Pharmaceuticals (NASDAQ:ZNTL) with a Outperform rating and raises Price Target to $8.